According to NHS Blood and Transplant, lung rejection is hard to detect as it can involve blood tests, biopsies and x-rays – despite happening in almost a third of patients.
Three months after having his transplant, White noticed a purple rash on the skin patch – with a biopsy showing mild rejection before he was treated with steroids.
“I definitely believe the skin patch helped to stop the lungs from being rejected,” he said.
“I’m over a year post-transplant now and doing really well. Who knows if that would be the case if the rash hadn’t shown up and rejection wasn’t spotted until further down the line.”
The Sentinel trial skin grafts are being carried out by plastic surgeons at the University of Oxford.
Henk Giele, chief investigator of Sentinel and an Oxford plastic surgeon said: “It seems logical that having a window to your transplant can provide an early warning system of rejection or reassure you that you don’t have rejection but we have to prove it works.
“We hope it will change what we know about transplant and makes patients lives better and longer,” he added.
The trial is set to run until 2027 and will recruit 152 patients at five centres; Freeman Hospital in Newcastle, Harefield Hospital in London, Queen Elizabeth Hospital in Birmingham, Royal Papworth in Cambridge and Wythenshawe Hospital in Greater Manchester.